πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

BioMarin Pharmaceutical Australia Patents

Full USPTO pharma patent portfolio for BioMarin Pharmaceutical Australia β€” grant dates, expiration, and drug cross-links.

Patents
175
Expiring ≀24m
2

Quick answer

BioMarin Pharmaceutical Australia has 175 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β€” use filters for patent-cliff planning.

Page 4 of 4

  1. US 8198242

    Variants of C-type natriuretic peptide

    Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8128925

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8088760

    Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP)

    Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8067416

    Methods and compositions for the treatment of metabolic disorders

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8012976

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8003126

    Stable tablet formulation

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7981864

    Methods and compositions for targeting proteins across the blood brain barrier

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7947737

    Method of treating hypertension and reducing serum lipase activity

    Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7947681

    Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

    Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7790433

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7776353

    Conjugated linoleic acid compositions

    Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7732599

    Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7722865

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7612073

    Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

    Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7601717

    Pterin analogs

    Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7566462

    Stable tablet formulation

    Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7566714

    Methods and compositions for the treatment of metabolic disorders

    Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7560263

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7553653

    Variants and chemically-modified variants of phenylalanine ammonia-lyase

    Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7537923

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7534595

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

    Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7531341

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7514096

    Triacylglycerols of enriched CLA content

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7452548

    Conjugated linoleic acid compositions

    Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7442372

    Delivery of therapeutic compounds to the brain and other tissues

    Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7354576

    Methods of treating diseases caused by deficiencies of recombinant Ξ±-L-iduronidase

    Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7264799

    Use of heparinases to decrease inflammatory response

    Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 6979563

    Attenuation of tumor growth, metastasis and angiogenesis

    Expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6972124

    Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

    Expires Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6866844

    Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

    Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6569661

    Recombinant &agr;-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof

    Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does BioMarin Pharmaceutical Australia have?

175 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do BioMarin Pharmaceutical Australia patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.